NEW YORK (GenomeWeb) – Contextual Genomics and the Personalized Medicine Initiative today announced that Pfizer Canada has joined the National Access Project for Cancer Testing.

Pfizer Canada has provided a grant of an undisclosed amount and technical support as part of its commitment to the consortium, whose goal is to provide genomic testing to all Canadians diagnosed with cancer and to accelerate a personalized approach to treating the disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.